Back to SRS Investment Management, LLC SRS Investment Management, LLC

TXGTXG
13 quarters

Position history for SRS Investment Management, LLCSRS Investment Management, LLC's holdings in 10x Genomics Inc Class A

SRS Investment Management, LLC previously held 0 shares of TXG (10x Genomics Inc Class A), worth $0 as of 2024-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$5.9M

Total Shares Change

-40,451

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$22.67
0
2024-Q2
New
504,257
-
$9.8M0.1%$19.45
47
2024-Q1
Exited
0
-100.0%
$00.0%$37.53
0
2023-Q4
Decreased
683,893
-34.8%
$38.3M0.5%$55.96
0
2023-Q3
Decreased
1M
-51.7%
$43.3M0.6%$41.25
0
2023-Q2
Decreased
2.2M
-27.7%
$121.4M1.4%$56.70
0
2023-Q1
Unchanged
3M
0.0%
$167.7M2.4%$52.05
0
2022-Q4
Unchanged
3M
0.0%
$109.5M2.0%$36.44
0
2022-Q3
Increased
3M
+9.0%
$85.6M1.7%$29.93
52
2022-Q2
Increased
2.8M
+1214.3%
$124.8M2.4%$46.20
84
2022-Q1
Unchanged
209,865
0.0%
$16M0.2%$74.74
0
2021-Q4
Increased
209,865
+418.8%
$31.3M0.4%$150.88
57
2021-Q3
New
40,451
-
$5.9M0.1%$145.94
39

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used